Clinical Trials Directory

Trials / Completed

CompletedNCT03290417

Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer

Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Men Managed With Active Surveillance for Prostate Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Case Comprehensive Cancer Center · Academic / Other
Sex
Male
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to see if eating vitamin D, omega 3 and turmeric (curcumin) slows the growth of prostate cancer in men on active surveillance.

Detailed description

The primary objective is to investigate the influence of vitamin D, omega-3 fatty acids, and turmeric curcumin intake on the genomic landscape of NCCN very low and low risk patients managed with Active Surveillance. This will be measured by using genomic signatures in Decipher GRID and using the mixed effect linear model that tests for the interaction of treatment arm and time (base-line, 6 month and 12 month time points) with gene expression as the response variable. The secondary objective is to evaluate prostate cancer aggressiveness pre and post intervention by looking at genes and gene signatures associated with vitamin D and omega-3 fatty acids pathways. Prognostic performance of GRID gene signatures will be evaluated using Active Surveillance 'Failure' (deferred treatment) as an additional endpoint. The exploratory objective is to be able to use predictive genes and/or genomic signatures to assess benefit from vitamin D, omega-3 fatty acid and turmeric curcumin intake. This will only be possible once sufficient patient follow up is available.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin D5000 IU/cap; One cap by mouth daily
DIETARY_SUPPLEMENTOmega-3720 mg/cap; one capsule by mouth 3 times per day
DIETARY_SUPPLEMENTTurmeric250mg/cap; two capsules by mouth 4 times per day

Timeline

Start date
2017-09-07
Primary completion
2019-06-20
Completion
2019-12-20
First posted
2017-09-21
Last updated
2020-02-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03290417. Inclusion in this directory is not an endorsement.